These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

779 related items for PubMed ID: 9554246

  • 1. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
    Fleming D, Davie J, Glasier A.
    Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
    [Abstract] [Full Text] [Related]

  • 2. Norplant implants in the UK: first year continuation and removals.
    Peers T, Stevens JE, Graham J, Davey A.
    Contraception; 1996 Jun; 53(6):345-51. PubMed ID: 8773421
    [Abstract] [Full Text] [Related]

  • 3. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ, Bromham DR, O'Connor TP, Sahota JE.
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [Abstract] [Full Text] [Related]

  • 4. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I, Stern J, Diaz S, Pavéz M, Alvarez F, Brache V, Mishell DR, Lacarra M, McCarthy T, Holma P.
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of Norplant implants among Thai women in Bangkok.
    Chompootaweep S, Kochagarn E, Sirisumpan S, Tang-usaha J, Theppitaksak B, Dusitsin N.
    Contraception; 1996 Jan; 53(1):33-6. PubMed ID: 8631187
    [Abstract] [Full Text] [Related]

  • 6. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA, Wang S, Rogers P, Vince G, Affandi B.
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [Abstract] [Full Text] [Related]

  • 7. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I, Campodonico I, Kiriwat O, Holma P, Diaz S, Wan L, Biswas A, Viegas O, el din Abdalla K, Anant MP, Pavez M, Stern J.
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [Abstract] [Full Text] [Related]

  • 8. Use of Norplant implants in a New York City clinic population.
    Gerber S, Westhoff C, Lopez M, Gordon L.
    Contraception; 1994 Jun; 49(6):557-64. PubMed ID: 8070260
    [Abstract] [Full Text] [Related]

  • 9. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R, Sheeder J, Arango N, Teal SB, Tocce K.
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [Abstract] [Full Text] [Related]

  • 10. Hormonal implants: contraception for a new century.
    Darney PD.
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
    [Abstract] [Full Text] [Related]

  • 11. Phase III clinical trial with Norplant II (two covered rods): report on five years of use.
    Contraception; 1993 Aug; 48(2):120-32. PubMed ID: 8403909
    [Abstract] [Full Text] [Related]

  • 12. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY, Yang YS, Tseng LH, Ko TM, Hsu MC, Chuang SM.
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [Abstract] [Full Text] [Related]

  • 13. Assessing the acceptability of Norplant contraceptive in four patient populations.
    Dugoff L, Jones OW, Allen-Davis J, Hurst BS, Schlaff WD.
    Contraception; 1995 Jul; 52(1):45-9. PubMed ID: 8521714
    [Abstract] [Full Text] [Related]

  • 14. Experience of Thai women in Bangkok with Norplant-2 implants.
    Chompootaweep S, Kochagarn E, Tang-Usaha J, Theppitaksak B, Dusitsin N.
    Contraception; 1998 Oct; 58(4):221-5. PubMed ID: 9866003
    [Abstract] [Full Text] [Related]

  • 15. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK, Affandi B, Korver T.
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [Abstract] [Full Text] [Related]

  • 16. Norplant subdermal contraceptive system: experience in Taiwan.
    Tseng LH, Lee TY, Yang YS, Ko TM, Chuang SM.
    Contraception; 1996 Mar; 53(3):177-80. PubMed ID: 8689883
    [Abstract] [Full Text] [Related]

  • 17. Pregnancy after removal of Norplant implants contraceptive.
    Affandi B, Santoso SS, Djajadilaga, Hadisaputra W, Moeloek FA, Prihartono J, Lubis F, Samil RS.
    Contraception; 1987 Aug; 36(2):203-9. PubMed ID: 3123134
    [Abstract] [Full Text] [Related]

  • 18. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L, Brache V, Meirik O, Ali M, Habib N, Landoulsi S, WHO Study Group on Contraceptive Implants for Women.
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [Abstract] [Full Text] [Related]

  • 19. Education and counseling for Norplant users.
    Hinkle LT.
    J Obstet Gynecol Neonatal Nurs; 1994 Jun; 23(5):387-91. PubMed ID: 8083779
    [Abstract] [Full Text] [Related]

  • 20. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I, Seifert S, Hendricks D, Jamshidi RM, Burke AE, Fox MC.
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.